MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Shares Outstanding (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Shares Outstanding (Entity) came in at $81.1 million in Q4 2025, up 3.47% YoY from $78.4 million in Q4 2024, and up 0.8% on a QoQ basis from $80.5 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Shares Outstanding (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Shares Outstanding (Entity) data on file, last reported at $81.1 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 3.47% year-over-year to $81.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $81.1 million (up 3.47% YoY) and the FY2025 annual result came in at $81.1 million, up 3.47% from the prior year.
  • Shares Outstanding (Entity) climbed to $81.1 million in Q4 2025, from $80.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $81.1 million in Q4 2025 to a low of $44.3 million in Q1 2021.
  • A 5-year average of $59.9 million and a median of $59.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) increased 0.81% — and 2023, when it soared 33.25%.
  • Tracing MGTX's Shares Outstanding (Entity) over 5 years: stood at $44.5 million in 2021, then grew by 8.82% to $48.5 million in 2022, then soared by 31.2% to $63.6 million in 2023, then gained by 23.26% to $78.4 million in 2024, then gained by 3.47% to $81.1 million in 2025.
  • The last three Shares Outstanding (Entity) figures came in at $81.1 million (Q4 2025), $80.5 million (Q3 2025), and $80.4 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 91.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 91.42 Mn
Dec 31, 2025 80.43 Mn
Sep 30, 2025 80.95 Mn
Jun 30, 2025 80.59 Mn
Mar 31, 2025 79.03 Mn
Dec 31, 2024 69.82 Mn
Sep 30, 2024 71.63 Mn
Jun 30, 2024 64.38 Mn
Mar 31, 2024 64.07 Mn
Dec 31, 2023 56.49 Mn
Sep 30, 2023 59.53 Mn
Jun 30, 2023 55.35 Mn
Mar 31, 2023 48.64 Mn
Dec 31, 2022 45.18 Mn
Sep 30, 2022 44.69 Mn
Jun 30, 2022 44.67 Mn
Mar 31, 2022 44.50 Mn
Dec 31, 2021 44.14 Mn
Sep 30, 2021 44.17 Mn
Jun 30, 2021 44.14 Mn